Viewing Study NCT05607004


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2025-12-26 @ 9:56 PM
Study NCT ID: NCT05607004
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2022-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Sponsor: Atossa Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ATOS-Z-201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View